Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.770
-0.010 (-0.56%)
At close: Feb 11, 2026, 4:00 PM EST
1.790
+0.020 (1.13%)
After-hours: Feb 11, 2026, 4:47 PM EST

Editas Medicine Revenue

Editas Medicine had revenue of $7.54M in the quarter ending September 30, 2025, with 12,265.57% growth. This brings the company's revenue in the last twelve months to $46.38M, down -24.90% year-over-year. In the year 2024, Editas Medicine had annual revenue of $32.31M, down -58.64%.

Revenue (ttm)
$46.38M
Revenue Growth
-24.90%
P/S Ratio
3.26
Revenue / Employee
$188,549
Employees
246
Market Cap
173.27M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202432.31M-45.81M-58.64%
Dec 31, 202378.12M58.41M296.32%
Dec 31, 202219.71M-5.83M-22.83%
Dec 31, 202125.54M-65.19M-71.85%
Dec 31, 202090.73M70.20M341.93%
Dec 31, 201920.53M-11.41M-35.71%
Dec 31, 201831.94M18.21M132.64%
Dec 31, 201713.73M7.68M126.80%
Dec 31, 20166.05M4.42M271.58%
Dec 31, 20151.63M--
Dec 31, 2014---